ATE216596T1 - Kolloidale radiomarkierte zusammensetzungen, deren anwendung und verfahren zu deren herstellung - Google Patents

Kolloidale radiomarkierte zusammensetzungen, deren anwendung und verfahren zu deren herstellung

Info

Publication number
ATE216596T1
ATE216596T1 AT91903521T AT91903521T ATE216596T1 AT E216596 T1 ATE216596 T1 AT E216596T1 AT 91903521 T AT91903521 T AT 91903521T AT 91903521 T AT91903521 T AT 91903521T AT E216596 T1 ATE216596 T1 AT E216596T1
Authority
AT
Austria
Prior art keywords
compositions
colloid
iron
radionuclide
radiom
Prior art date
Application number
AT91903521T
Other languages
English (en)
Inventor
Jaime Simon
Lance A Cooper
Kenneth Mcmillan
David A Wilson
Original Assignee
Mallinckrodt Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Medical Inc filed Critical Mallinckrodt Medical Inc
Application granted granted Critical
Publication of ATE216596T1 publication Critical patent/ATE216596T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
AT91903521T 1989-12-27 1990-12-18 Kolloidale radiomarkierte zusammensetzungen, deren anwendung und verfahren zu deren herstellung ATE216596T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/458,049 US5061476A (en) 1989-12-27 1989-12-27 Radiolabeled colloid compositions and method for preparing same
PCT/US1990/007522 WO1991009622A1 (en) 1989-12-27 1990-12-18 Radiolabeled colloid compositions, their use and process for their preparation

Publications (1)

Publication Number Publication Date
ATE216596T1 true ATE216596T1 (de) 2002-05-15

Family

ID=23819152

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91903521T ATE216596T1 (de) 1989-12-27 1990-12-18 Kolloidale radiomarkierte zusammensetzungen, deren anwendung und verfahren zu deren herstellung

Country Status (7)

Country Link
US (1) US5061476A (de)
EP (1) EP0460205B1 (de)
JP (1) JP3155273B2 (de)
AT (1) ATE216596T1 (de)
CA (1) CA2046308C (de)
DE (1) DE69033953T2 (de)
WO (1) WO1991009622A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268129A (en) * 1991-02-15 1993-12-07 The Dow Chemical Company Layered mixed metal hydroxides for the stabilization of radioactive colloids
US5137709A (en) * 1991-02-15 1992-08-11 The Dow Chemical Company Layered mixed metal hydroxides for the stabilization of radioactive colloids
US5429582A (en) * 1991-06-14 1995-07-04 Williams; Jeffery A. Tumor treatment
WO1995016463A1 (en) * 1992-09-23 1995-06-22 The Dow Chemical Company Radioactive compositions and their use for radiation ablation treatment
KR100190957B1 (ko) * 1995-03-10 1999-06-15 김성년 방사성 키토산 착물, 방사성 키토산 응집입자 및 방사성키토산 착물 제조용 키트, 그리고 그들의 제조방법 및 용도
US5762903A (en) * 1995-03-10 1998-06-09 Korea Atomic Energy Research Institute Radioactive chitosan complex for radiation therapy
EP0730870A1 (de) * 1995-03-10 1996-09-11 Korea Atomic Energy Research Institute Radioaktiver Chitosankomplex und seine Makroaggregate zur Anwendung in der internen Strahlentherapie und Verfahren zu ihrer Herstellung
DE19511276C2 (de) * 1995-03-27 1999-02-18 Immuno Ag Adjuvans auf der Basis kolloidaler Eisenverbindungen
US5924973A (en) 1996-09-26 1999-07-20 The Trustees Of Columbia University In The City Of New York Method of treating a disease process in a luminal structure
WO1998019740A1 (en) * 1996-11-05 1998-05-14 Duke University Radionuclide production using intense electron beams
JP2002530128A (ja) 1998-11-18 2002-09-17 ラジオバスキュラー、システムズ、リミテッド、ライアビリティ、カンパニー 放射性コーティング溶液、方法および基板
CN100450553C (zh) * 2006-11-16 2009-01-14 沈阳 可降解放射性海绵及其制造工艺
KR102006599B1 (ko) 2011-12-21 2019-08-01 아이소테라퓨틱스 그룹 엘엘씨 방사성 조성물 및 그의 치료적 사용 방법
JP2016520650A (ja) * 2013-06-05 2016-07-14 アール−エヌエーヴィ・エルエルシー スズ−１１７ｍでの免疫性、炎症性及び変形性関節炎の治療
KR20160113496A (ko) * 2015-03-20 2016-09-29 이화여자대학교 산학협력단 무기 고분자 하이브리드 콜로이드 화합물 및 그의 제조 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898724A (en) * 1984-06-04 1990-02-06 The Dow Chemical Company Organis amine phosphonic acid complexes for the treatment of calcific tumors
US4897254A (en) * 1984-09-21 1990-01-30 The Dow Chemical Company Radioactive compositions for the treatment of calcific tumors
US4849209A (en) * 1985-06-07 1989-07-18 Cadema Medical Products, Inc. Treatment of arthritis, including rheumatoid arthritis with 166 Holmium radionuclide
US4752464A (en) * 1985-06-07 1988-06-21 Cadema Medical Products, Inc. Treatment of arthritis, including rheumatoid arthritis, with radioactive isotopes
US4758429A (en) * 1985-11-04 1988-07-19 Gordon Robert T Method for the treatment of arthritis and inflammatory joint diseases
US4906450A (en) * 1987-03-26 1990-03-06 Ephraim Lieberman Treatment of arthritis, including rheumatoid arthritis, with the radionuclide, tin SN-121
US4915932A (en) * 1987-10-14 1990-04-10 Australian Nuclear Science & Technology Organisation Macroaggregates for radiation synovectomy
US4889707A (en) * 1988-01-29 1989-12-26 The Curators Of The University Of Missouri Composition and method for radiation synovectomy of arthritic joints
US4970062A (en) * 1989-05-30 1990-11-13 The United States Of America As Represented By The United States Department Of Energy Colloid labelled with radionuclide and method
HU900222D0 (en) * 1990-01-22 1990-04-28 Peter Teleki Process for giving 5b-10, 45rh-103 isotops to ferrofluidic ferric oxide, advantageous stopping vital functions of cancerous cells
WO1991015240A1 (en) * 1990-04-11 1991-10-17 Teleki Peter Method of preparing an iron oxide composition for therapeutic treatment of a living body and iron oxide composition

Also Published As

Publication number Publication date
JPH04505023A (ja) 1992-09-03
CA2046308A1 (en) 1991-06-28
DE69033953T2 (de) 2002-10-17
EP0460205A4 (en) 1993-07-28
JP3155273B2 (ja) 2001-04-09
DE69033953D1 (de) 2002-05-29
US5061476A (en) 1991-10-29
EP0460205A1 (de) 1991-12-11
WO1991009622A1 (en) 1991-07-11
EP0460205B1 (de) 2002-04-24
CA2046308C (en) 2000-11-28

Similar Documents

Publication Publication Date Title
ATE216596T1 (de) Kolloidale radiomarkierte zusammensetzungen, deren anwendung und verfahren zu deren herstellung
SE8305535L (sv) Lekemedelspreparat med antinikotinverkan och forfarande for framstellning derav
RU93054941A (ru) Композиции, содержащие наночастицы, на поверхности которых адсорбирован тилоксапол, способ получения наночастиц, способ диагностики, применение наночастиц
ZA832580B (en) N-glycosylated carboxamide derivatives,process for their preparation and their use for influencing the body's inherent defences
IT1162895B (it) Solfonammidi derivate da 3 benziliden canfora e loro applicazione come filtri per raggi ultravioletti in particolare nelle composizioni cosmetiche
ATE150310T1 (de) Oral anzuwendende suspension bestehend aus stabilisiertem rockenpulver eines hydratisierten cephalosporins
IT8219908A0 (it) Derivati di ferro biodisponibile esenti da gastrolesivita',procedimento di preparazione e relative composizioni farmaceutiche.
JPS5750928A (en) Diagnostic agent for scanning bone
EP0153992A3 (en) Water soluble derivatives of 3,5-diaceto amido-2,4,6-triiodobenzoic acid and process for their preparation and use
DE2961609D1 (en) Sila-substituted 1,4-dihydropyridine derivatives, processes for their preparation, pharmaceutical compositions and process for their preparation
DE3377212D1 (en) New substituted derivatives of 2,5-diamino 1,4-diazole, preparation methods thereof and pharmaceutical compositions containing them
PT79389B (en) Process for the preparation of 1,2-dithyolane derivates and pharmaceutical compositions containing said derivates
HUT47796A (en) Herbicide compositions containing new 2-substituted imino-1,3,4-dihydro-thiadiazols as active components and process for producing the active components
PT77593B (en) Method of treating 2-alpha-cyano-4-alpha 5-alpha-epoxy-3-oxo-steroid compounds and a process for the preparation of pharmaceu-tical compositions containing the same with a controlled particle size
FR2701952B1 (fr) Nouveaux dérivés cyclopeptidiques de l'angiopeptine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
HUT40648A (en) Process for producing optically active substituted 1,4-dihydro-pyridines and pharmaceutical compositions containing them as active agents
IL72467A0 (en) New 1,2-diaryl-3-azolylpropane derivatives,their preparation and their use as agents for the treatment of plants
DE3461187D1 (en) N-cyclopropylmethyl-2-oxo-3-diparamethoxyphenyl-5,6-triazines, process for its preparation and their use as pharmaceutical preparations
ZA845618B (en) New 1,2-diaryl-3-azolylpropane derivatives,their preparation and their use as agents for the treatment of plants
FR2528829B1 (fr) Composes polyprenyliques, procedes pour leur preparation et composition therapeutique les contenant
FR2652086B1 (fr) Compose nouveau d'origine vegetale, derive de l'acide cafeique, l'oraposide; composition a usage therapeutique et composition dermato-cosmetique le contenant.
ATA234589A (de) Neue 2-methoxycarbonyl substituierte n,n'-di(trimethoxybenzoyl)piperazine, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
FI910509L (fi) Menetelmä oraalisesti, nestemäisessä muodossa annettavan hiukkasjauheen valmistamiseksi
BAE et al. Clinical Trial of Dysprosium-165 HMA in the Treatment of Rheumatoid Knee Synovitis
秦厚荣 2-Sylow Subgroups of K2OF for Real Quadratic Fields F

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties